Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments TrendingStockAlerts · Mar 2, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy TrendingStockAlerts · Mar 1, 2026
Kanazawa University research: Wnt signaling drives stomach cancer spread by reshaping surrounding tissue TrendingStockAlerts · Feb 26, 2026
disAMR Acquires AMR Insights to Build the Leading Global Hub for Antimicrobial Resistance (AMR) Innovation, Investment, and Policy Alignment TrendingStockAlerts · Feb 25, 2026
Heat-Stable Probiotics Market to Reach USD 12.7 Billion by 2036 as Shelf-Stable Functional Foods and Spore-Forming Strains Drive Global Growth TrendingStockAlerts · Feb 24, 2026
TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years TrendingStockAlerts · Feb 23, 2026
Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial TrendingStockAlerts · Feb 22, 2026
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference TrendingStockAlerts · Feb 21, 2026
Phenylketonuria Market to Reach New Heights by 2034, Driven by Innovative Therapies and Rising Diagnosis Rates | DelveInsight TrendingStockAlerts · Feb 20, 2026
